Monoamine Oxidase, Obesity and Related Comorbidities: Discovering Bonds
- 16 December 2021
- book chapter
- Published by Springer Nature
- p. 199-213
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Adipose tissue dysfunction contributes to obesity related metabolic diseasesBest Practice & Research Clinical Endocrinology & Metabolism, 2013
- Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injuryBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Mitochondrial monoamine oxidase‐A‐mediated hydrogen peroxide generation enhances 5‐hydroxytryptamine‐induced contraction of rat basilar arteryBritish Journal of Pharmacology, 2010
- Lipopolysaccharide-Induced Epithelial Monoamine Oxidase Mediates Alveolar Bone Loss in a Rat Chronic Wound ModelThe American Journal of Pathology, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Monoamine oxidase inactivation: From pathophysiology to therapeuticsAdvanced Drug Delivery Reviews, 2008
- Global burden of obesity in 2005 and projections to 2030International Journal of Obesity, 2008
- Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitorsPharmacological Research, 2008
- Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker ratsPharmacological Research, 2007
- Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytesBiochimie, 2007